Bright Minds Biosciences ...

NASDAQ: DRUG · Real-Time Price · USD
41.80
-0.74 (-1.74%)
At close: Aug 15, 2025, 3:59 PM
42.13
0.78%
After-hours: Aug 15, 2025, 07:25 PM EDT

Bright Minds Biosciences Income Statement

Financials in CAD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-3.35M n/a -764.46K -887.39K -468.77K -1.62M -1.55M -1.43M -1.96M -2.26M -2.97M -2.65M -4.38M -4.72M -2.95M -3.6M -1.49M -580.55K
Interest Income
509.38K 4.32K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-2.95M 49.61K -749.32K 214.92K -574.14K -1.68M -1.53M -1.46M -2.05M -2.34M -2.96M -2.66M -4.49M -4.86M -2.87M -3.53M -1.58M -677.06K
Net Income
-2.95M 49.61K -749.32K 214.92K -574.14K -1.68M -1.53M -1.46M -2.05M -2.34M -2.96M -2.66M -4.49M -4.86M -2.87M -3.53M -1.58M -677.06K
Selling & General & Admin
676.16K 540.93K 348.4K 320.64K 363.6K 398.21K 459.16K 380.32K 562.64K 797.69K 430.86K 603.28K 640.58K 876.35K 744.99K 887.05K 449.34K 227.76K
Research & Development
2.56M 1.05M 416.06K 566.75K 105.18K 1.23M 1.09M 1.05M 1.4M 1.46M 2.54M 2.05M 3.74M 3.85M 2.21M 2.71M 1.04M 352.79K
Other Expenses
112.84K 38.35K n/a n/a n/a n/a -0.00 0.00 -0.00 -0.00 n/a n/a 0.00 -0.00 0.00 n/a 0.00 0.00
Operating Expenses
3.35M 1.62M 764.46K 887.39K 468.77K 1.62M 1.55M 1.43M 1.96M 2.26M 2.97M 2.65M 4.38M 4.72M 2.95M 3.6M 1.49M 580.55K
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
86.34K 78.2K 5K n/a n/a 36.6K 36.6K 37.1K 4.65K 41.07K 74.59K 80.12K 176.87K 220.28K 146.46K 473.53K 218.88K 13.29K
Cost & Expenses
3.35M 1.62M 764.46K 887.39K 468.77K 1.62M 1.55M 1.43M 1.96M 2.26M 2.97M 2.65M 4.38M 4.72M 2.95M 3.6M 1.49M 580.55K
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
4.46M 4.46M 4.46M 4.46M 4.46M 3.84M 3.77M 3.77M 3.79M 3.59M 2.98M 2.37M 2.37M 2.37M 2.37M 2.26M 1.39M 1.16M
Shares Outstanding (Diluted)
4.65M 4.65M 4.65M 4.65M 4.46M 3.84M 3.77M 3.77M 3.79M 3.59M 2.98M 2.37M 2.37M 2.37M 2.37M 2.26M 1.39M 1.16M
EPS (Basic)
-0.66 0.01 -0.17 0.05 -0.13 -0.44 -0.41 -0.39 -0.56 -0.68 -0.98 -1.12 -1.9 -2.05 -1.21 -1.56 -1.14 -0.65
EPS (Diluted)
-0.63 0.01 -0.17 0.05 -0.13 -0.44 -0.41 -0.39 -0.56 -0.68 -0.98 -1.12 -1.9 -2.05 -1.21 -1.56 -1.14 -0.65
EBITDA
-3.33M -1.6M -772.29K 252.85K -553.9K -1.66M -1.51M -1.44M -2.03M -2.31M -2.95M n/a n/a n/a n/a n/a n/a n/a
EBIT
-3.35M -1.62M -791.31K 234.74K -572.02K -1.7M -1.59M -1.45M -2.05M -2.3M -3.01M -2.66M -4.48M -4.82M -2.97M -3.65M -1.55M -617.22K
Depreciation & Amortization
22.48K 21.53K 19.02K 18.11K 18.11K 18.11K 18.11K 18.11K 18.11K 18.11K 6.04K 2.65M 4.38M 4.72M 2.95M 3.6M 1.49M 580.55K